Long-acting formulations, such as dulaglutide, liraglutide, and once-weekly exenatide, have consistently shown superior efficacy in reducing both fasting plasma glucose and HbA1c levels when compared to shorter-acting alternatives like twice-daily exenatide and lixisenatide (Htike et al
The SURPASS trial series spans five major trials with combined enrollment exceeding 10,000 participants, establishing the most comprehensive GLP-1 agonist evidence base in existence
You have plateaued on GLP-1 monotherapy
( B ) cAMP responses in islets isolated from Pdx1 Cre-ERT CAMPER mice (expressing the cAMP reporter T EPAC VV in beta cells) (63) preincubated with control (Veh) or lipoprotein-deficient serum (LPDS) media supplemented with 10 M simvastatin (LPDS/simv) overnight and stimulated with 100 nM Ex-4 in G6 followed by 16 mM glucose (G16) and 100 M IBMX + 10 M FSK for maximal response
Keep it away from the freezer compartment, as freezing destroys the peptide structure
Is there a pill form for GLP-1